Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Sanuwave Health Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Sanuwave Health Q2 Earnings Call Highlights

Key Points

ARKO Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Personal care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/44547be2-b411-43fb-91ed-bf4a69577d94.png
ARKO Q2 Earnings Call Highlights

Key Points

CART Q2 Earnings Miss, Revenues Beat on GTV and Ad Growth
CART Q2 Earnings Miss, Revenues Beat on GTV and Ad Growth

Maplebear Inc. CART, doing business as Instacart, delivered mixed second-quarter 2026 results, with earnings falling short of the Zacks Consensus Estimate, while revenues surpassed expectations. The

BMRN Stock Up as Q2 Earnings Beat on Sales Growth, 2026 Outlook RaisedPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
BMRN Stock Up as Q2 Earnings Beat on Sales Growth, 2026 Outlook Raised

BioMarin Pharmaceutical BMRN reported second-quarter 2026 adjusted earnings of $1.20 per share, which beat the Zacks Consensus Estimate of 96 cents. However, the bottom line declined 16.7% year over

Is ZETA Worth Buying Now as Growth Surges but Valuation Stays Rich?
Is ZETA Worth Buying Now as Growth Surges but Valuation Stays Rich?

Zeta Global Holdings Corp. ZETA is delivering faster growth, deeper customer spending and stronger cash generation, but its valuation already reflects a meaningful portion of that progress.

The

ADM Stock: Growth Gains vs. Valuation and Execution Risks Remain Ahead
ADM Stock: Growth Gains vs. Valuation and Execution Risks Remain Ahead

Archer Daniels Midland Company ADM has strengthened its earnings outlook as improved crushing and ethanol conditions, a recovery in Nutrition and cost initiatives support profit growth. The stock

INTR vs. BAM: Which Stock Is the Better Value Option?
INTR vs. BAM: Which Stock Is the Better Value Option?

Investors interested in stocks from the Financial - Miscellaneous Services sector have probably already heard of Inter & Co. Inc. (INTR) and Brookfield Asset Management (BAM). But which of these two

Is SPCX Worth Buying as Starlink Growth Battles Heavy AI Spending?: https://staticx-tuner.zacks.com/images/articles/main/6c/175454.webp
Is SPCX Worth Buying as Starlink Growth Battles Heavy AI Spending?

Space Exploration Technologies Corp. SPCX combines a fast-growing Starlink franchise, expanding AI monetization and a launch platform built around reusable rockets. Those businesses give the company

SPCX Fell 24.5% in the Past Month: Is the Sell-Off an Opportunity?Photo, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
SPCX Fell 24.5% in the Past Month: Is the Sell-Off an Opportunity?

Space Exploration Technologies Corp. SPCX shares have fallen 24.5% in the past month even as the company posted rapid second-quarter growth across its three operating segments. The sell-off has

GMED Q2 Earnings Call Highlights Margin Gains and Revenue CautionPhoto, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
GMED Q2 Earnings Call Highlights Margin Gains and Revenue Caution

Globus Medical, Inc. GMED used its second-quarter 2026 call to emphasize margin execution and continued spine share gains, while management flagged Nevro and Enabling Technologies as risks within

Portman Ridge Finance Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus,  Asset management firm, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-4Gf80r47YD589EFtjlMy4oXE.png?st=2023-05-06T14%3A52%3A24Z&se=2023-05-06T16%3A52%3A24Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-06T00%3A39%3A24Z&ske=2023-05-07T00%3A39%3A24Z&sks=b&skv=2021-08-06&sig=d8x8qxYEsZ8AfRwcBw8eUkxkNQFVf9GobJgEag27Xug%3D
Portman Ridge Finance Q2 Earnings Call Highlights

Key Points

Matson (MATX) Upgraded to Strong Buy: Here's Why
Matson (MATX) Upgraded to Strong Buy: Here's Why

Investors might want to bet on Matson (MATX), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting

All You Need to Know About Credit Acceptance (CACC) Rating Upgrade to Buy
All You Need to Know About Credit Acceptance (CACC) Rating Upgrade to Buy

Investors might want to bet on Credit Acceptance (CACC), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting

STWD Stock Dips as Q2 Earnings Match Estimates, Revenues Rise Y/Y
STWD Stock Dips as Q2 Earnings Match Estimates, Revenues Rise Y/Y

Shares of Starwood Property Trust, Inc. STWD fell 1.73% during yesterday’s trading session after reporting second-quarter 2026 results. The company reported second-quarter 2026  distributable

Is Tyson Worth Buying as Chicken Strength Battles Beef Margin Risk?
Is Tyson Worth Buying as Chicken Strength Battles Beef Margin Risk?

Tyson Foods, Inc. TSN presents investors with a sharp trade-off. Chicken and Prepared Foods are delivering solid profits, while Beef remains a major drag on earnings visibility.

The stock’s

Tyson Cuts Beef Outlook as Q3 Volume Slumps, What It Means for 2026
Tyson Cuts Beef Outlook as Q3 Volume Slumps, What It Means for 2026

Tyson Foods, Inc. TSN entered the final stretch of fiscal 2026 with a sharper split across its portfolio. Chicken and Prepared Foods remained productive, but worsening Beef economics pressured

Time to Buy Nvidia or SpaceX Stock After Their AI Partnership?Photo, wide shot, wide-angle lens,  Computer hardware manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.theapi.app/temp/bee95973-d201-429b-849e-52867059bd1a.png
Time to Buy Nvidia or SpaceX Stock After Their AI Partnership?

As two of Wall Street's most covered stories, Nvidia NVDA) and SpaceX SPCX) are drawing attention after announcing a major partnership that will see SpaceX exclusively deploy Nvidia's

3 Reasons Growth Investors Will Love Sterling Infrastructure (STRL)
3 Reasons Growth Investors Will Love Sterling Infrastructure (STRL)

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't

3 Reasons Why Growth Investors Shouldn't Overlook Trekor (TGB)
3 Reasons Why Growth Investors Shouldn't Overlook Trekor (TGB)

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth

3 Reasons Why Growth Investors Shouldn't Overlook RBC Bearings (RBC)
3 Reasons Why Growth Investors Shouldn't Overlook RBC Bearings (RBC)

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth